Point72 DIFC Ltd Purchases New Shares in 23andMe Holding Co. (NASDAQ:ME)

Point72 DIFC Ltd acquired a new stake in shares of 23andMe Holding Co. (NASDAQ:ME) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 110,061 shares of the company’s stock, valued at approximately $43,000.

A number of other hedge funds have also recently bought and sold shares of the company. China Universal Asset Management Co. Ltd. grew its holdings in shares of 23andMe by 68.3% in the first quarter. China Universal Asset Management Co. Ltd. now owns 60,653 shares of the company’s stock valued at $32,000 after acquiring an additional 24,604 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its stake in 23andMe by 410.4% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 88,555 shares of the company’s stock valued at $35,000 after purchasing an additional 71,204 shares during the period. Levin Capital Strategies L.P. purchased a new stake in shares of 23andMe during the 2nd quarter valued at $61,000. Mirador Capital Partners LP raised its stake in shares of 23andMe by 11.2% during the 1st quarter. Mirador Capital Partners LP now owns 340,946 shares of the company’s stock worth $181,000 after purchasing an additional 34,321 shares during the period. Finally, Wittenberg Investment Management Inc. boosted its holdings in shares of 23andMe by 63.9% in the 1st quarter. Wittenberg Investment Management Inc. now owns 2,290,945 shares of the company’s stock worth $1,219,000 after buying an additional 893,552 shares during the last quarter. 36.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, TD Cowen downgraded shares of 23andMe from a “strong-buy” rating to a “strong sell” rating in a report on Wednesday, August 7th.

23andMe Trading Down 7.6 %

23andMe stock opened at $0.29 on Monday. The business’s 50 day simple moving average is $0.35 and its 200 day simple moving average is $0.43. 23andMe Holding Co. has a 12 month low of $0.29 and a 12 month high of $1.04. The company has a market cap of $144.18 million, a price-to-earnings ratio of -0.21 and a beta of 1.19.

23andMe (NASDAQ:ME) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.14) EPS for the quarter. 23andMe had a negative net margin of 317.03% and a negative return on equity of 83.22%. The firm had revenue of $40.41 million for the quarter, compared to analysts’ expectations of $50.30 million.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.